AGP Executive Report

Pharma Dealmaking: GSK agreed to buy Nuvalent for $10.6B, a major move aimed at rebuilding its oncology footprint. Biotech Funding: City Therapeutics raised $99.5M to push two RNAi programs toward the clinic, while Eloxx Pharmaceuticals priced a $66M offering. Access & Value-Based Care: CMS’s ACCESS Model is framed as a next step in disease management, adding more digital and outcome-linked reimbursement for cardio-kidney-metabolic, musculoskeletal, and behavioral health tracks. Health Tech M&A: ResMed completed its acquisition of Noctrix Health to expand nonpharmacologic wearable treatment for restless legs syndrome. Policy & Equity: A study in JAMA Network Open links unmet social needs—especially housing instability and transportation barriers—to lower colorectal cancer screening rates. Workforce & Care Delivery: A federal lawsuit alleges a hospital mishandled COVID vaccine exemption requests, triggering religious and medical discrimination claims.

Food Safety Recall: Clover Hill Dairy is voluntarily recalling soft ricotta/requeson cheese after possible Listeria monocytogenes contamination, with distribution across several states and Washington, DC. Workplace Safety: A 24-year-old technician was killed when a customer’s vehicle fell off a lift at an auto shop in Stuart, Florida; OSHA is involved. Insurance Policy: Illinois state Sen. Dave Koehler backed a “down coding” bill aimed at stopping insurers from underpaying diagnostic work when the final diagnosis differs from early test results. Digital Health & Revenue Cycle: Indiana University Health is partnering with Ensemble to scale its revenue cycle model, targeting reduced inefficiencies and a better patient financial experience. Sleep Tech M&A: ResMed completed its acquisition of Noctrix Health to expand nonpharmacologic treatment options for restless legs syndrome. Healthcare Access: Hayat Pharmacy is running prescription transfer events ahead of a nearby Walgreens closure in Milwaukee. Public Health Preparedness: Angola updated its national Ebola contingency plan, emphasizing lab capacity, digital surveillance, and protection for healthcare workers. Healthcare Workforce: Red Deer Polytechnic will build a $120M Healthtech Centre to train 1,000 students and support Alberta’s growing healthcare staffing needs.

Metabolic Health Tech: AQP One expanded its FDA-listed JBA AICare platform with BioBaseline metabolic modeling and GLP-1-related trend intelligence, aiming to turn longitudinal signals into actionable cardiometabolic insights. Preventive Wearables in Indonesia: Actxa and LIF launched the LIF Core Smart Ring with AI Glucose Scan after a trial with 800+ participants, pushing non-invasive glucose monitoring into everyday preventive care. Sleep Tech Deal: Resmed completed its acquisition of Noctrix Health to bring a noninvasive, nonpharmacologic wearable therapy for restless legs syndrome into its connected sleep portfolio. Respiratory Therapy Launch: Tactile Medical rolled out the next-gen AffloVest HFCWO system, targeting chronic neuromuscular and respiratory conditions with comfort and connected-care upgrades. Cancer Prevention Vaccine: Oxford and Moderna are starting a trial this summer of an mRNA vaccine for Lynch syndrome to train the immune system to eliminate pre-cancerous cells. Mental Health Gap: A report calls out chronic underinvestment in mental health infrastructure and the lack of clear pathways to care. Public Health Regulation: Fiji’s WAF and Ministry of Health are seeking clearer role definitions in rural water and sanitation approvals under a proposed Public Health Bill. Healthcare Business & Access: Kenya’s Tibu Health secured funding to expand pharmacy-based “Minute Clinics” and boost primary care access.

Health Policy & Costs: A new federal rule changes the No Surprises Act independent dispute process, cutting IDR administrative fees and standardizing how insurers communicate out-of-network payment decisions. Insurance Contract Fallout: Main Line Health warns a UnitedHealthcare contract dispute could push 32,000 Medicare Advantage and employer-plan patients out of network later this month. Maternal Health: Florida Healthy Start Coalitions and Sunshine Health launched a campaign to flag maternal warning signs, citing a D+ March of Dimes report card with high preterm birth and maternal mortality rates. Digital Health & AI: UB unveiled a Center for Translational AI and Digital Health aimed at faster, point-of-care diagnostics and patient-side tools. Wearables: Apple previewed watchOS 27 with upgraded Siri and deeper health tracking, including alerts tied to perimenopause/menopause signals. Clinical/Medtech Launches: Back On Trac won attention for an FDA-cleared seated prenatal spinal traction option; Xenix Medical rolled out its FDA-cleared Lux expandable lumbar fusion system. Public Health & Outbreaks: WHO reported Ebola cases topped 500 in Congo with spread into Uganda amid insecurity and attacks on response sites. Research & Wellness: Studies highlighted tea compounds for gut, metabolism and mood, plus a link between sleep apnea and cardiovascular risk via circadian disruption.

Sleep & Heart Risk: New research links obstructive sleep apnea to cardiovascular harm via inflammation, oxidative stress, and circadian clock disruption. Biotech Manufacturing: Dark Horse Consulting Group and Altruist Biologics plan to streamline global biologics development and cGMP manufacturing in China. Diagnostics Expansion: ABL Diagnostics is rolling out HybridChek, combining amplicon and hybrid capture sequencing for HIV and tuberculosis whole-genome testing. Cancer Drug Delivery: Sanofi’s Sarclisa gets EU approval in a subcutaneous on-body injector format for multiple myeloma, aiming to reduce clinic burden. Targeted Drug Pipeline: Amphista’s IND for AMX-883 clears, setting up a Phase 1 trial in relapsed/refractory AML and high-risk MDS. Company Deal: Japan’s GNI Group will buy Ayumi Pharmaceutical from Blackstone in a ~$280M deal to expand its pain-management and rheumatology footprint. Nursing Home Watch (CMS): CMS ratings highlight wide variation in Q1 2026 performance, from 5-star Kensington Health & Rehabilitation to 1-star Village Health Care Center. Wellness Industry: Aker BioMarine kicks off Vitality Month 2026 in Frankfurt with a brain-health and healthy-ageing program. Public Health Pressure: Bangladesh faces a dengue surge alongside a major measles outbreak, straining hospitals and pediatric care. Health Tech & Data: A guide spotlights Apple Health–Google Health integration for cross-platform tracking, while a separate study uses whole-body PET/CT to map metabolic changes after bariatric surgery.

Parkinson’s Care Gets Social: At the ATMRD Congress, Robert Cochrane, PhD framed connection and support groups as a “therapeutic dose” alongside meds and rehab, with telehealth helping patients build wider networks. Huntington’s Quality-of-Life Signals: Real-world survey results presented at ATMRD suggest deutetrabenazine may improve patient and caregiver-reported quality of life in Huntington disease chorea. RCC Adjuvant Spotlight: A deep dive into the Phase 3 RAMPART trial weighed durvalumab+tremelimumab’s disease-free survival gains against higher toxicities, calling for better biomarkers to guide adjuvant choices. Obesity Drug Data: Boehringer Ingelheim’s survodutide Phase III results reported targeted visceral and liver fat reductions with limited lean-mass loss, plus MASLD liver-fat normalization signals. Diabetes Pipeline: Antag Therapeutics shared early Phase 1 and preclinical combo data for AT7687, aiming for once-weekly obesity and cardiometabolic use. Regulation & Safety: Maharashtra’s FDA raid found unsterilised gloves falsely labeled sterile, while Nepal’s council discussed licensing delays for medical microbiologists. Access & Coverage Pressure: Florida’s Obamacare marketplace faces insurer pullbacks, raising “death spiral” concerns for remaining enrollees. Public Health Policy: Nepal’s health ministry flagged plans to amend its health insurance act, and Nigeria’s Niger Delta set up equipment support for primary care.

Diabetes Tech: A randomized CONNECT trial at ADA 2026 found Dexcom G7 CGM cut A1C by 1.6% over 26 weeks in adults with type 2 diabetes not using insulin, with results strong enough to support broader primary-care use. Obesity/GLP-1 Pipeline: Phase 3 data at ADA 2026 showed retatrutide delivering substantial weight loss and A1C improvements in both type 2 diabetes and obesity/overweight groups. Regulation & Access: Telangana’s Drugs Control Administration inspected 166 medical shops tied to online pharmacies and issued show-cause notices to 41 over issues like missing bills, weak prescription record-keeping, and dispensing without valid prescriptions. Aging & Care Delivery: Qatar launched “Ahlan Oral Health 2026” to boost oral health for older adults via community and home visits plus training for caregivers and healthcare staff. Long-Term Care Watch: CMS Q1 2026 ownership and star ratings highlighted wide variation across U.S. nursing homes, with some facilities scoring 5 stars while others sat at 1, alongside reported fines and penalties. Wellness Industry: The Retreat Costa Rica debuted its Vida Mía Longevity Centre with physician-guided nervous system and “cellular regeneration” programming. Clinical Research Buzz: An AI-designed universal coronavirus vaccine completed its first human trial with a reported 100% safety profile and multi-strain immune response.

Medical Devices & Regulation: Flagstaff startup Corvention got FDA clearance for its KardiaPSI balloon catheter, enabling minimally invasive treatment for critically ill U.S. heart valve patients, with a phased rollout focused on training and clinical support. Obesity Drugs: ADA 2026 data on investigational monthly GLP-1 berobenatide (VESPER-1 OLE and VESPER-3) point to meaningful weight loss and a shift from weekly to monthly dosing. Cancer Research Funding: New York earmarked $2M for 9/11 first-responder genomic cancer research at Albert Einstein College of Medicine, aiming to expand testing and earlier detection. Health Tech & Public Health Preparedness: Philadelphia built a mobile disease-testing lab and expanded wastewater monitoring ahead of the FIFA World Cup to speed detection of infections like measles and norovirus. Healthcare Costs & Antitrust: Arizona sued major insurers and cost-management firm Claritev (formerly MultiPlan), alleging a coordinated pricing scheme that suppressed payments to providers. Mental Health & Access: A new clinic expansion in Ontario adds space and clinicians to de-stigmatize mental health care, with continued virtual options. AI & Health Systems: UN-linked reporting warns AI data centers could dramatically increase water use by 2030, raising new sustainability pressure on health-adjacent infrastructure.

Public Health Funding: San Juan County expects a $346,000 cut to its Foundational Public Health Services budget for 2026-2027, with officials weighing options as state and revenue shortfalls loom. Courts & Safety: In Tennessee, day four of the Randy Vega trial featured the medical examiner describing injuries in a fatal DUI crash that killed a mother and her 1-year-old son. Nursing Home Watch: CMS data across multiple states shows wide variation in care quality and enforcement—some facilities earned 4–5 stars with no fines, while others posted 1-star ratings alongside repeated fines and penalties. Drug Approvals: Aurobindo Pharma won final US FDA approval for generic tofacitinib tablets, and Alembic Pharmaceuticals received final approval for haloperidol tablets. Opioid Treatment R&D: GATC Health’s Morgantown lab reported early progress on a potential opioid use disorder drug, with human trials ahead. Medical Cannabis Access: Kentucky opened a new medical cannabis dispensary in Bowling Green and highlighted faster card access for qualifying patients. Global Pharma Regulation: Saudi Arabia and Russia signed an MoU to strengthen pharmaceutical cooperation, including GMP and inspection training. Litigation: A US jury sided with Johnson & Johnson in a talc ovarian cancer case, finding no negligence in selling cosmetic talc products. Infectious Disease Alert: India reported a suspected Ebola case in Jaipur involving a Ugandan visitor, with lab confirmation pending.

Cancer & Cost Savings: Queen’s University researchers report that a prescribed exercise program after colon cancer treatment cut recurrence risk by 28% and death risk by 37%, and that access to exercise programs can also lower overall health-system costs. Mental Health & AI Use: RAND data in JAMA Pediatrics finds a sharp rise in teens using AI chatbots for mental health support, with a fifth of youth reporting use when stressed or upset—raising questions about the right role for clinicians. Pediatrics Tech: A first-in-human study describes a handheld, noninvasive optical device that can distinguish necrotizing enterocolitis from healthy tissue in premature infants within minutes, potentially enabling earlier treatment. Medicare Payment Reform: CMS’s ACCESS model (starting July 5) is set to shift primary and specialty care for chronic conditions toward outcome-based, technology-supported delivery. Fraud Crackdown: DOJ launched a state-federal partnership to target health care fraud, beginning in Ohio, with enhanced oversight for hospice-related concerns. Health Tech in the Wild: Washington University and Genentech-backed work uses AI to speed review of 3D eye scans and improve detection of retinal diseases. Industry & Access: Kansas groups expand rural telemedicine via Avel eCare, aiming to strengthen emergency, inpatient, and behavioral health services close to home. Legal Pressure on Drug Programs: Three health systems sue CVS over alleged diversion of 340B savings, arguing funds meant for safety-net hospitals were improperly retained. Water Safety: Puerto Rico’s SwimSafe P.R. 2.0 rolls out real-time water safety tools to reduce drowning risk across waterways.

AI in Healthcare: Meta says health will be central to its next AI push, with Alexandr Wang arguing models must deliver practical health capabilities at scale. Wearables & Early Detection: Mirror Caring is developing a non-invasive knee patch that tracks swelling and motion after exercise, aiming to flag problems earlier. Neonatal Screening Tech: Precision Learning’s EEG-based infant tool for language delay faces mainland China access limits until it secures an NMPA license, currently restricting reach to private hospitals. Faster Infection Testing: Emerging Viral Diagnostics is pitching a simplified PCR system that targets 45 pathogens in about 90 minutes to help clinicians decide on antibiotics sooner. Connected Fertility: Soonr Health launched in the U.S. with at-home dyadic ovulation and hormone testing via its Surearly SMART device. Healthcare Data & Privacy: KFF reports HHS is seeking access to state systems holding identifiable medical records as RFK Jr. pursues a vaccine-autism link. Nursing Home Watch: CMS ownership and rating updates highlight wide performance swings across facilities, from 5-star outliers to 1–2 star homes. Policy & Industry: Trump announced nearly $700M in support for struggling coal plants using Cold War-era authority, underscoring ongoing health-and-environment stakes tied to energy policy.

Workforce & Inclusion: UVM Health’s Project SEARCH wrapped up with eight graduates, including a young woman with Down syndrome and Type 1 diabetes, showing how structured hospital rotations can build real workplace skills and independence. Mental Health Access: Wisconsin providers report rising demand as workforce shortages persist, with state data flagging major youth mental health strain. Everyday Care Tips: Mercy Health shared practical guidance to prevent and manage swimmers’ ear, emphasizing avoiding cotton swabs and using safe at-home drainage steps. Military Mental Health: Defense Health Agency’s inTransition program offers brief coaching and help finding follow-on care for service members during transitions. Pharma Execution: A new industry push argues clinical trial execution is becoming pharma’s competitive advantage as fragmented systems and enrollment delays drive billion-dollar costs and long timelines. Digital Health Privacy: Ultrahuman says hackers accessed internal analytics and exposed a small slice of wellness data, renewing concerns about smart-ring health privacy. Retail Pharmacy Access: Walgreens plans to close a Chatham, Chicago store, raising fears of pharmacy deserts as officials push for more access points. Drug Development: FDA cleared Amneal’s ready-to-use romidepsin for cutaneous T-cell lymphoma, filling a gap after Teva’s withdrawal. Health Tech & AI: Alnylam struck an AI partnership with Inceptive Nucleics to speed RNA therapy discovery, with deal value potentially reaching $2B. Public Health & Safety: Texas confirmed a New World screwworm case, triggering quarantine and livestock movement restrictions.

Post-acute care compliance: Matrix Medical Network and HealthFair agreed to pay $56.5M to settle claims that they submitted false Medicare Advantage diagnosis codes, with the Justice Department saying the practice inflated CMS payments. AI in home health: IO Health launched “AI Validation” to flag and correct clinical documentation discrepancies at the point of care, aiming to cut rework and claim denials for home health and hospice agencies. Mental health support models: Douglas County behavioral health leaders are exploring a clubhouse model for adults with serious mental illness, emphasizing peer-led, non-clinical skill-building and a structured work-ordered day. Maternal care recognition: Harris Health Ben Taub Hospital was named among America’s Best Maternity Hospitals 2026, highlighting quality metrics and women/infant services. Drug pricing policy pressure: Public Citizen urged Congress to rein in pharmaceutical patent and monopoly abuses driving the U.S. drug pricing crisis. Health workforce & training: Kenya’s medical services leadership called on universities to translate research into local manufacturing and skills for vaccines, diagnostics, and medicines. Nursing home oversight: CMS data showed Rock Creek Health and Rehabilitation (Texas) earned a 3-star overall rating in Q1 2026, with two penalties totaling $32,034. Nutrition funding: Protein snack brand Phab raised $4M pre-Series A to expand in India’s health and wellness market.

Medical Innovation: A University of Missouri team reports a way to protect pancreatic islet transplants in type 1 diabetes without whole-body immunosuppressive drugs, using engineered immune-regulating molecules to improve graft survival. Obesity Treatment Access: Novo Nordisk says oral Wegovy is set to reach UAE pharmacies within days, with the rollout framed as obesity care moving toward long-term disease management. Public Health & Prevention: A study in JAMA links prolonged sitting (over 10 hours/day) with higher risks of adverse pregnancy outcomes like gestational diabetes and preeclampsia. Healthcare Policy & Costs: Patient groups launch a campaign against Medicare competitive bidding for urological and ostomy supplies, warning “lowest bid” rules could limit access and raise complications. Workplace Mental Health: New survey findings tie toxic workplace culture and poor mental health to lower benefits use and reduced vacation-taking. Tech in Care: Microsoft previews Copilot Health, aiming to tailor guidance using user-provided medical records and connected health data. Industry Expansion: SCHOTT Pharma expands in Pennsylvania, tripling US manufacturing capacity for drug containment vials. Local Health Access: Omaha teens tell the mayor mental health support must be proactive, not just crisis response. Rural Care Funding: Michigan is set to receive $173M for rural health transformation, with calls to spread proven models statewide.

Health Insurance Pressure: Ireland’s private health premiums rose 10.6% on average last year while coverage shrank, with many plans restricting orthopaedic benefits like joint replacements—leaving more people exposed to higher out-of-pocket costs. Nursing Home Oversight: CMS data show multiple for-profit facilities in Virginia and Kentucky carrying 1-star overall ratings in Q1 2026, with reported fines at some sites—raising questions about staffing and resident care quality. Detention Health Access: New Jersey AG sued GEO Group to force full health-inspector access to the Delaney Hall ICE detention center, citing unsafe and unsanitary conditions; DHS pushed back. Cancer Pipeline at ASCO: ASCO 2026 highlighted radioligand progress in prostate cancer, including CONVERGE-01 Part 3 testing Ac-225 rosopatamab tetraxetan in Lu-PSMA pretreated mCRPC. Tech + Patient Privacy: The AHA backed Endeavor Health in an appeal over website tracking tied to patient privacy claims, arguing the “crime-tort” exception shouldn’t apply. Wearables Innovation: New screen-free fitness tracker hardware is trending toward continuous biometric capture and enterprise customization, reflecting a shift in how health data is collected.

Health AI Governance: A Mount Sinai-led index finds U.S. health AI rules are growing fast but stay fragmented, mostly advisory, and focused on transparency—leaving enforceable, clear obligations still hard to pin down. Insurance Tech & Policy: Minnesota moves toward tighter oversight of AI in health insurance prior authorizations, requiring licensed physician review for denials. Provider Workforce: A new push argues health systems must help build the physician workforce of the future, including creating long-term training pathways. Medical Devices & Imaging: ResMed closes its $340M Noctrix deal, adding a restless legs syndrome home device to its sleep portfolio; Macao’s Union Medical Centre introduces Macau’s first 3T MRI simulation positioning system for more precise radiotherapy planning. Access & Affordability: The UAE launches an add-on letting residents lock health insurance premiums for up to five years. Public Health & Safety: New Jersey seeks court action to force health inspectors into the Delaney Hall ICE facility amid allegations of poor conditions and medical neglect. Workplace Safety: Calgary’s LX Hausys Canada Inc. is fined $350K after a 2023 forklift fatality, with the penalty tied to VR forklift simulator development. Mental Health in the Community: Carson Tahoe Health expands a prevention-focused mobile mental health program for youth via Vehicles of Change. Drug Development Setback: Fulcrum Therapeutics starts a strategic review after FDA effectively blocks a sickle cell drug development path. Healthcare Business Ops: SwiftAuth rolls out AI automation for prior authorizations and referrals to cut administrative burden.